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ABSTRACT
Objective To evaluate the association of overall and
specific headaches with volume of white matter
hyperintensities, brain infarcts, and cognition.
Design Population based, cross sectional study.
Setting Epidemiology of Vascular Ageing study, Nantes,
France.
Participants 780 participants (mean age 69, 58.5%
women) with detailed headache assessment.
Main outcome measures Brain scans were evaluated for
volume of white matter hyperintensities (by fully
automated imaging processing) and for classification of
infarcts (by visual reading with a standardised
assessment grid). Cognitive function was assessed by a
battery of tests including the mini-mental state
examination.
Results 163 (20.9%) participants reported a history of
severe headache and 116 had migraine, of whom 17
(14.7%) reported aura symptoms. An association was
found between any history of severe headache and
increasing volume of white matter hyperintensities. The
adjusted odds ratio of being in the highest third for total
volume of white matter hyperintensities was 2.0 (95%
confidence interval 1.3 to 3.1, P for trend 0.002) for
participants with any history of severe headache when
compared with participants without severe headache
being in the lowest third. The association pattern was
similarforallheadachetypes. Migrainewithaurawasthe
only headache type strongly associated with volume of
deep white matter hyperintensities (highest third odds
ratio 12.4, 1.6 to 99.4, P for trend 0.005) and with brain
infarcts (3.4, 1.2 to 9.3). The location of infarcts was
predominantly outside the cerebellum and brain stem.
Evidence was lacking for cognitive impairment for any
headache type with or without brain lesions.
ConclusionsInthispopulationbasedstudy,anyhistoryof
severe headache was associated with an increased
volume of white matter hyperintensities. Migraine with
aura was the only headache type associated with brain
infarcts.Evidencethatheadacheof anytypebyitselfor in
combination with brain lesions was associated with
cognitive impairment was lacking.
INTRODUCTION
Many people in the general population have primary
and often disabling headache disorders.
1-3 The most
common forms are migraine and tension-type head-
ache. Migraine is a recurrent primary headache disor-
der that has close links to the neuronal and
cerebrovascularsystem,andinsomepatientsisaccom-
panied by transient neurological symptoms, mostly of
the visual field, known as migraine aura.
Headaches in general and migraine in particular
have been associated with an increased risk of
comorbidities.
14 Evidence is accumulating that
migraine with aura is a marker for increased risk of
cardiovascular disease,
5-7 specifically stroke.
89In addi-
tion, migraine has been associated with a variety of
structural brain lesions, including clinically silent
infarct-like lesions
1011 in the posterior circulation terri-
tory and with white matter hyperintensities (lesions
appearinginwhitematteronmagneticresonanceima-
gingofthebrain).Whitematterhyperintensitiescanbe
seen in some apparently healthy people
12 and in
patients with motor and cognitive dysfunctions.
13-16
These lesions have been commonly interpreted as
lesions of ischaemic origin, which is consistent with
their association with vascular risk factors
1718 and
increased risk of ischaemic stroke.
16
Several studies have reported an association
between migraine and white matter
hyperintensities.
19-22 A meta-analysis indicated a four-
fold increased risk for these lesions in people with
migraine compared with controls.
23 Many uncertain-
ties remain, however, as some of the studies linking
migraine with white matter hyperintensities had no
direct migraine-free control group,
20 did not include
people over age 60,
222425 or used a case-control
design.
23 Furthermore, initial evidence suggests that
other headache types are also associated with white
matter hyperintensities,
26 but most studies had no
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BMJ | ONLINE FIRST | bmj.com page 1 of 9information on non-migraine headache. In addition, it
remains unclear whether structural brain lesions
among people with headache are associated with
impairedcognitivefunction.Weevaluatedtheassocia-
tion of overall and specific headache types with
volume of white matter hyperintensities and infarct
lesions as well as with cognitive performance in the
population based Epidemiology of Vascular Ageing
study.
METHODS
The Epidemiology of Vascular Ageing study is a long-
itudinal study that recruited men and women born
between 1922 and 1932 from the electoral rolls of the
city of Nantes, France, without specific exclusion
criteria.
27 During the baseline visit (1991-3), 1389 par-
ticipantswereenrolled.Inafacetofaceinterviewatthe
examination centre, standardised questionnaires were
usedtoascertaininformationaboutdemographicsand
medical history as well as personal characteristics and
habits, such as cigarette and alcohol consumption.
Trainedstaffmeasuredheight,weight,andbloodpres-
sureand tookfastingbloodsamplesfollowingstandar-
dised procedures.
28 Written informed consent was
obtained from all participants.
Headache assessment
Informationonheadachewasascertainedinatwostep
approach among 1188 people who participated in the
second follow-up visit, four years after the baseline
visit. Firstly, during a face to face interview, trained
staff asked participants standardised questions about
lifetime history of severe headaches and headache fea-
tures.Interviewerswerespeciallytrainedtoadminister
the questionnaire and to ask the questions. Inter-
viewerswereinstructedtoinsistonthescreeningques-
tion about headache history to avoid missing
participants with a potential for recurrent severe head-
achesduringtheirlifetimeandparticularlyduringtheir
young adulthood.
29 Secondly, participants who
reported a history of severe headaches were asked to
take part in a telephone interview with a neurologist
specialised in headaches using a structured
questionnaire.
30 This questionnaire has been shown
to have good inter-rater agreement (κ=0.83)
31 and
included information on duration of headaches; life-
time frequency of episodes; intensity of the pain; char-
acteristics and location of the pain; association of the
pain with physical activity; associated features, such as
sensitivity to sound and light as well as nausea; and
information about aura features. A total of 242 partici-
pants were eligible for the interview. Of those, four
died before the interview, four were unreachable or
opted not to participate, and one had severe hearing
impairment, leaving 233 participants who were inter-
viewed. Information on detailed lifetime history of
headache, specific migraine features, and aura symp-
toms were ascertained during the interview.
The collected information allowed classification of
headache based on the second revision of the Interna-
tionalClassificationofHeadacheDisorders.
32Weclassified
patients who reported a history of severe headache as
having migraine if the headache and associated fea-
tures fulfilled all or all but one of the classification cri-
teria for migraine without aura.
32 In addition, we
classifiedpatientswithmigraineaccordingtomigraine
aura status. Participants with a history of headache not
fulfillingthecriteriaformigrainewereclassifiedashav-
ing non-migraine headache, a group of patients likely
tohavetension-typeheadachebecauseotherheadache
types are rare in the general population.
33
Magnetic resonance imaging examination
Atthesecondfollow-upvisit(atthesametimeasascer-
tainment of headache), 845 participants (88% partici-
pation rate) underwent cerebral magnetic resonance
imaging, as described in detail elsewhere.
17 Partici-
pants had similar baseline characteristics to those
whodidnotparticipate.
17Thedistributionofheadache
status was also similar between the two groups
(P=0.38).
Brain scanning was carried out with a 1.0 tesla scan-
ner (Magnetom Expert; Siemens, Erlangen, Ger-
many), with the orbitomeatal line as reference.
Firstly, we acquired a high resolution T1 weighted
brain volume using a three dimensional inversion
Table 1 |Association of headache status with personal characteristics and volume of white
matter hyperintensities (WMH) in Epidemiology of Vascular Ageing study (n=780). Values are
numbers (percentages) unless stated otherwise
Variable
No history of
severe headache
(n=617)
Migraine
headache
(n=116)
Non-migraine
headache
(n=47)
Mean (SD) age (years) 68.8 (2.9) 68.9 (2.8) 69.5 (3.1)
Women 331 (53.6) 99 (85.3) 26 (55.3)
Mean (SD) systolic blood pressure (mm Hg) 135.1 (19.6) 131.7(20.5) 137.2 (21.7)
Mean (SD) cholesterol level (mmol/L) 6.1 (1.0) 6.3 (1.0) 6.1 (0.7)
Mean (SD) low density lipoprotein cholesterol level
(mmol/L)
3.8 (0.9) 4.0 (0.9) 3.8 (0.8)
Mean (SD) triglyceride level (mmol/L) 1.3 (0.6) 1.3 (0.6) 1.4 (0.7)
Mean (SD) glucose level (mmol/L) 5.5 (1.1) 5.3 (1.2) 5.5 (0.7)
Body mass index:
<25 271 (44.4) 48 (42.5) 18 (39.1)
25-29.9 255 (41.7) 55 (48.7) 19 (41.3)
≥30 85 (13.9) 10 (8.8) 9 (19.6)
Ever smoker 277 (44.9) 33 (28.4) 21 (44.7)
Alcohol intake (g/day):
0 162 (26.3) 53 (45.7) 13 (27.7)
1-19 270 (43.8) 43 (37.1) 22 (46.8)
20-39 112 (18.2) 16 (13.8) 6 (12.8)
≥40 73 (11.8) 4 (3.4) 6 (12.8)
History of hypertension 215 (34.8) 51 (44.0) 18 (38.3)
Family history of severe headache 154 (25.0) 49 (42.2) 21 (44.7)
History of cardiovascular disease 44 (7.1) 7 (6.0) 5 (10.6)
Median (interquartile range) total WMH volume (cm
2) 3.3 (2.2-5.0) 3.5(2.4-6.0) 3.8 (2.9-6.8)
Median (interquartile range) deep WMH volume (cm
2) 0.8 (0.5-1.4) 1.0(0.6-1.6) 1.1 (0.7-1.6)
Median(interquartilerange)periventricularWMHvolume
(cm
2)
2.3 (1.5-3.8) 2.7(1.4-4.6) 2.6 (1.9-5.0)
Percentages may not add up to 100% owing to rounding or missing values.
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time 97 ms, echo time 4 ms, inversion time 300 ms,
sagittal acquisition). The volume matrix was
128×256×256, slice thickness 1.4 mm, and pixel size
0.9×0.9 mm
2. We obtained T2 weighted and proton
densityweightedbrainimagesusingatwodimensional
axial turbo spin echo sequence (repetition time 3500
ms, first echo time 15 ms, second echo time 85 ms)
with 26 slices (each 5 mm thick). The acquisition
matrix was 256×256 over a 23 cm transversal field of
view and the pixel size was 0.9×0.9 mm
2.
Image processing and categorisation of white matter
hyperintensities
We analysed brain scans using previously validated
automated imaging processing.
34 Briefly, we used a
three step process: preprocessing, including registra-
tion, removal of non-brain tissue, and correction for
bias field; detection of white matter hyperintensities
on T2 weighted images, including removal of false
positives; and post-processing, including the genera-
tion of probability maps for white matter hyperinten-
sities and details. For each detected lesion we
computed the localisation and volume. When the dis-
tance of the detected white matter hyperintensities to
the ventricular system was less than 10 mm, we
labelled the location of the lesions as periventricular,
otherwise we labelled the lesions as deep white matter
hyperintensities. The algorithm correlated well with a
semiquantitative visual rating carried out by a neuror-
adiologist (quadratic trend with Scheltens scale
P<0.001).
34
We log transformed the measures for volume of
white matter hyperintensities as they were not
normally distributed. Next, we standardised the
volume of white matter hyperintensities to the total
volume of white matter. Standardisation with total
intracranial volume yielded similar results. Finally,
we a priori categorised all measures for volume of
white matter hyperintensities into tertiles to allow for
non-linear patterns of association.
Assessment of infarct lesions
One neurologist with training in neuroradiology
(YCZ), who was blinded to the headache status and
any other clinical data of participants, used a standar-
dised assessment grid to visually review all the brain
scans. The characteristics of lesions were visualised
simultaneously in axial, coronal, and sagittal planes.
A brain infarct was defined as focal lesions of 3 mm
ormorewiththesamesignalcharacteristicsascerebro-
spinal fluid on both T1 and T2 weighted sequences,
and these were discriminated from dilated vascular
space(Virchow-Robinspace)accordingtotheirshapes
and locations. We applied this definition to all lesions
irrespectiveoflocation.Anendpointcommittee(YCZ,
HC, CT, and TK) reviewed and classified doubtful
lesions after consensus. For this analysis, we distin-
guished between infarcts in the cerebellum or brain
stem and in other locations.
Assessment of cognitive function
TheEpidemiologyof VascularAgeingstudycollected
extensive data on cognitive performance,
27 using the
mini-mental state examination, Wechsler adult intelli-
gencescale-revised,trailmakingtestpartAandB,Rey
15 item memory test, Raven progressive matrices,
Benton visual retention test, Benton facial recognition
Table 2 |Association between headache history and volume of white matter hyperintensities (WMH) in Epidemiology of Vascular Ageing study (n=780)
WMH volume by
thirds
No history of severe headache
(n=617)
Migraine headache
(n=116)
Non-migraine headache
(n=47)
No (%) No (%)
Age adjusted odds
ratio (95% CI)
Multiple adjusted*
odds ratio (95% CI) No (%)
Age adjusted odds
ratio (95% CI)
Multiple adjusted*
odds ratio (95% CI)
Total:
Lowest third 215 (34.8) 35 (30.2) 1.0 1.0 10 (21.3) 1.0 1.0
Middle third 211 (34.2) 34 (29.3) 1.0 (0.6 to 1.6) 1.0 (0.6 to 1.6) 15 (31.9) 1.5 (0.7 to 3.5) 1.6 (0.7 to 3.6)
Highest third 191 (31.0) 47 (40.5) 1.5 (0.9 to 2.4) 1.8 (1.0 to 2.9) 22 (46.8) 2.4 (1.1 to 5.2) 2.7 (1.2 to 5.9)
P for trend†—— 0.07 0.03 — 0.03 0.01
Deep:
Lowest third 213 (34.5) 34 (29.3) 1.0 1.0 13 (27.7) 1.0 1.0
Middle third 214 (34.7) 34 (29.3) 1.0 (0.6 to 1.7) 1.1 (0.7 to 2.0) 12 (25.5) 1.0 (0.4 to 2.2) 1.0 (0.4 to 2.2)
Highest third 190 (30.8) 48 (41.4) 1.6 (1.0 to 2.6) 1.9 (1.1 to 3.2) 22 (46.8) 2.0 (1.0 to 4.0) 2.1 (1.0 to 4.4)
P for trend†—— 0.04 0.01 — 0.04 0.03
Periventricular:
Lowest third 215 (34.8) 36 (31.0) 1.0 1.0 9 (19.1) 1.0 1.0
Middle third 210 (34.0) 33 (28.4) 0.9 (0.6 to 1.6) 0.9 (0.5 to 1.5) 17 (36.2) 1.9 (0.8 to 4.3) 2.0 (0.9 to 4.7)
Highest third 192 (31.1) 47 (40.5) 1.5 (0.9 to 2.4) 1.6 (1.0 to 2.7) 21 (44.7) 2.5 (1.1 to 5.6) 2.9 (1.3 to 6.5)
P for trend†—— 0.09 0.04 — 0.03 0.01
Odds ratios are calculated by using a multinomial logistic regression model with participants who had no history of severe headache and who were in lowest third for WMH volume as
reference group. WMH volume was standardised to total white matter volume. Percentages may not add up to 100% owing to rounding.
*Adjusted for age, sex, history of hypertension, smoking, body mass index, total cholesterol level, alcohol consumption, and family history of severe headache.
†P for trend across mean values of the WMH thirds calculated by using a logistic regression model contrasting a specific headache group to participants without history of severe headache.
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trained psychologists and we used data ascertained at
the second follow-up visit. As all tests gave a similar
associationpatternandthemini-mentalstateexamina-
tion is the most widely used test of global cognitive
function, we report findings from the mini-mental
state examination only.
35 This test includes simple
questions in several domains, such as time and loca-
tion, repeating lists of words, arithmetic (for example,
serial sevens), language use and comprehension, and
basic motor skills.
Statistical analysis
Of the 845 participants with brain scans, we excluded
20 for technical reasons, eight because of cerebral
anomalies, 28 with image contrast precluding the
application of the algorithm for measuring volume of
white matter hyperintensities, and nine with missing
information on headache history, leaving 780 partici-
pants for this study. Eleven participants had missing
information for the mini-mental state examination
and were excluded from that part of the analysis.
We compared the means of continuous characteris-
tics and frequency of categorical characteristics of par-
ticipants according to their headache status. We used
multinominal logistic regression models to calculate
odds ratios and 95% confidence intervals of the asso-
ciation betweenheadache status and thirds for volume
ofwhitematterhyperintensitiesusingparticipantswho
did not report a history of severe headache and who
were in the lowest third for volume of white matter
hyperintensities as the reference group. Multinomial
logistic regression is an extension of binary logistic
regression that allows the outcome variable to have
more than two categories. Calculated odds ratios
have two reference categories, one for the exposure
(headache status) and one for the outcome (thirds for
volume of white matter hyperintensities) categories.
We run age adjusted and multivariable adjusted
modelsfortotalandlocalisedwhitematterhyperinten-
sities. The multivariable models controlled for age
(continuous), sex, history of hypertension (yes, no),
smoking (ever, never), body mass index (<25, 25 to
29,≥30weight(kg)/(height(m)
2),alcoholconsumption
(0, 1-19, 20-39, ≥40 g/day), serum total cholesterol
level (continuous), and family history of severe head-
ache(yes,no).Resultsremainedessentiallyunchanged
whenthemodelswereadditionallycontrolledforahis-
toryofdiabetes,systolicbloodpressure,andhistoryof
vascular disease. We calculated P for trend across
mean values of the categories for volume third by
using a logistic regression model contrasting a specific
headache type to participants without a history of
headache.
Because the volumes of localised and total white
matterhyperintensitiesarecorrelated,weusedtheresi-
dual method
36 to evaluate the association between
headache types and volume of localised white matter
hyperintensities—that is, deep or periventricular—
above and beyond the association with the total
volume.
In exploratory analyses we stratified the association
between headache status and volume of white matter
hyperintensities (highest third v lowest two thirds) by
age (<70, ≥70 years), sex, history of hypertension,
Table 3 |Association between headache and volume of WMH volume in Epidemiology of Vascular Ageing study (n=780)
WMH volume by
third
No history of severe headache
(n=617)
Migraine with aura
(n=17)
Migraine without aura
(n=99)
No (%) No (%)
Age adjusted odds
ratio (95% CI)
Multiple adjusted*
odds ratio (95% CI) No (%)
Age adjusted odds
ratio (95% CI)
Multipleadjusted*
oddsratio(95%CI)
Total (n=260):
Lowest third 215 (34.8) 4 (23.5) 1.0 1.0 31 (31.3) 1.0 1.0
Middle third 211 (34.2) 5 (29.4) 1.3 (0.3 to 4.8) 1.2 (0.3 to 4.6) 29 (29.3) 1.0 (0.6 to 1.6) 0.9 (0.5 to 1.6)
Highest third 191 (31.0) 8 (47.1) 2.3 (0.7 to 7.8) 2.7 (0.8 to 9.3) 39 (39.4) 1.4 (0.8 to 2.4) 1.6 (0.9 to 2.8)
P for trend†— — 0.16 0.07 — 0.15 0.08
Deep (n=260):
Lowest third 213 (34.5) 1 (5.9) 1.0 1.0 33 (33.3) 1.0 1.0
Middle third 214 (34.7) 6 (35.3) 6.0 (0.7 to 50.0) 6.2 (0.7 to 52.5) 28 (28.3) 0.8 (0.5 to 1.5) 1.0 (0.6 to 1.7)
Highest third 190 (30.8) 10 (58.8) 11.2 (1.4 to 88.3) 12.4 (1.6 to 99.4) 38 (38.4) 1.3 (0.8 to 2.1) 1.6 (0.9 to 2.7)
P for trend†— — 0.008 0.005 — 0.24 0.11
Periventricular
(n=260):
Lowest third 215 (34.8) 5 (29.4) 1.0 1.0 31 (31.3) 1.0 1.0
Middle third 210 (34.0) 4 (23.5) 0.8 (0.2 to 3.1) 0.8 (0.2 to 3.1) 29 (29.3) 1.0 (0.6 to 1.6) 0.9 (0.5 to 1.6)
Highest third 192 (31.1) 8 (47.1) 1.8 (0.6 to 5.7) 2.1 (0.7 to 6.8) 39 (39.4) 1.4 (0.8 to 2.3) 1.6 (0.9 to 2.7)
P for trend†— — 0.24 0.12 — 0.16 0.10
Odds ratios are calculated by using a multinomial logistic regression model predicting WMH categories with participants who had no history of severe headache and who were in the lowest
third for WMH volume as reference group. WMH volume was standardised to total white matter volume. Percentages may not add up to 100% owing to rounding.
*Adjusted for age, sex, history of hypertension, smoking, body mass index, total cholesterol level, alcohol consumption, and family history of severe headache. The multinomial model also
includes participants with non-migraine headache (n=47); see table 2 for detailed numbers.
†P for trend across mean values of thirds for WMH volume calculated by using a logistic regression model contrasting specific headache group to participants without history of severe
headache.
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ache, and history of cardiovascular disease, adjusting
for age. We further evaluated whether the association
between migraine and volume of white matter hyper-
intensities was modified by full classification criteria
for migraine.
32 We evaluated statistically significant
effect modification by including interaction terms in
the models.
We used an age adjusted logistic regression model to
calculateoddsratioofinfarctsaccordingtoheadachesta-
tus.Wedidnotaimtoadjustforadditionalpotentialcon-
foundersbecauseoftherelativelylownumberofinfarcts
in subgroups. When we ran such models, however, the
effect estimates were not meaningfully different.
We used general linear models, adjusting for age,
sex, and education, to evaluate the association of the
mini-mental state examination according to headache
type with and without structural brain lesions. Evalua-
tion of the results for performance of other cognitive
tests showed a similar association pattern (data not
shown). All analyses were done using SAS version
9.1; P values were two tailed and we considered
P<0.05 to be statistically significant.
RESULTS
Of the 780 participants with complete information on
headachesandbrainscans,163 (20.9%)reporteda his-
tory of severe headache. Of the 116 participants with
migraine,17(14.7%)reportedaurasymptoms.Table 1
summarises the association between personal charac-
teristics and headache status. Participants with
migraine were more likely to be female, to be never
smokers, and to be less likely to drink alcohol when
compared with participants who did not report a his-
tory of headaches. Both migraine and non-migraine
headache groups were more likely to have a positive
family history of severe headaches.
When the association between any history of head-
achesandvolumeofwhitematterhyperintensitieswas
evaluated, stronger associations were found with
increasing volume. For participants with any history
of severe headache, the multivariable adjusted odds
ratio of being in the highest volume third for total
white matter hyperintensities was 2.0 (95% confidence
interval 1.3 to 3.1, P for trend 0.002) compared with
participants who were in the lowest third and who did
not have a headache history. Similar associations were
foundforvolumeofdeepwhitematterhyperintensities
(2.0, 1.3 to 3.1, P for trend 0.002) and for volume of
periventricular white matter hyperintensities (1.9, 1.2
to 3.0, P for trend 0.004).
Whena distinctionwasmadebetweenmigraineand
non-migraine headache, the risk increased for both
headache types, with higher estimates for the group
with non-migraine headaches (table 2).
Table 3 summarises the association between
migraine and volume of white matter hyperintensities
by migraine aura status. Although the association pat-
ternofmigrainewithoutauraandvolumeofwhitemat-
terhyperintensitieswasofthesamemagnitudeasthose
foroverallheadache,strongerassociationswere found
between migraine with aura and lesions located in the
deep white matter (12.4, 1.6 to 99.4 for the highest
third,Pfortrend0.005).Thisassociationremainedsig-
nificant when the correlation between volume of loca-
lised and total white matter hyperintensities was taken
into account (5.8, 1.2 to 27.8, P for trend 0.02).
We evaluated whether the association between
headache status and increased total volume of white
matter hyperintensities (highest third v lowest two
thirds) was modified by age, sex, history of hyperten-
sion, smoking status, family history of severe head-
ache, history of cardiovascular disease, or
classification criteria for headache status. A significant
interaction of the association between non-migraine
headacheandtotalvolumeofwhitematterhyperinten-
sities was found by age only (P for interaction 0.03),
indicating a significant association among participants
aged 70 and older (3.4, 1.5 to 8.0).
A total of 110 (14.1%) participants had at least one
braininfarctand28hadmorethanone(table 4).Com-
pared with participants without a history of severe
headache, those with a history of overall migraine or
non-migraine headache had no increased risk of a
brain infarct. Only participants who had migraine
with aura had over a threefold increased risk (3.4, 1.2
to 9.3). Furthermore, there was a suggestion that parti-
cipants who had migraine with aura were at increased
Table 4 |Frequency of infarcts according to location and headache status in Epidemiology of Vascular Ageing study (n=780).
Values are numbers (percentages)
Location
No of participants
affected
No history of
severe headache
(n=617)
Non-migraine
headache (n=47)
Any migraine
(n=116)
Migraine with
aura (n=17)
Migraine without
aura (n=99)
C o r t e x 1 1 9( 1 . 5 ) 1( 2 . 1 ) 1( 0 . 9 ) 0( 0 ) 1( 1 . 0 )
Subcortex 42 34 (5.5) 1 (2.1) 7 (6.0) 2 (11.8) 5 (5.1)
Nucleus lentiformis 32 26 (4.2) 0 (0) 6 (5.2) 2 (11.8) 4 (4.0)
Nucleus caudatus 20 17 (2.8) 1 (2.1) 2 (1.7) 1 (5.9) 1 (1.0)
Thalamus 14 11 (1.8) 1 (2.1) 2 (1.7) 2 (11.8) 0 (0)
Internal capsule 5 5 (0.8) 0 (0) 0 (0) 0 (0) 0 (0)
B r a i ns t e m 8 7( 1 . 1 ) 0( 0 ) 1( 0 . 9 ) 0( 0 ) 1( 1 . 0 )
Cerebellum 19 17 (2.8) 0 (0) 2 (1.7) 1 (5.9) 1 (1.0)
Multiple infarcts 28 23 (3.7) 1 (2.1) 4 (3.4) 2 (11.8) 2 (2.0)
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were located outside of the cerebellum or brain stem
(3.5, 1.2 to 10.2).
Mini-mentalstateexaminationscoreswereavailable
foratotalof769participants,withscoresrangingfrom
17to30(mean27.6(SD)2.1).Meanscoresadjustedfor
age, sex, and education did not differ according to
headache status (P=0.17). Results were similar when
median values were compared (data not shown). The
mean score was highest among participants who had
migraine with aura (score 28.4). Evidence was lacking
that cognitive function was impaired for participants
with migraine or non-migraine headache according
to structural brain lesions (table 5). Evidence was
also lacking for cognitive impairment according to
brain lesions in participants who had migraine with
aura (data not shown).
DISCUSSION
Inthislarge,crosssectionalpopulationbasedsampleof
older participants (mean age 69) we found that any life-
timehistoryofsevereheadacheswasassociatedwithan
increasedriskofhighervolumesoftotal,deep,andperi-
ventricular white matter hyperintensity. The pattern of
association was similar for both migraine and non-
migraine headache types. Conversely, evidence was
lacking that a history of severe headache in general
was associated with brain infarcts, although such an
associationwasfoundforthesmallgroupofparticipants
who had migraine with aura. Finally, we found no evi-
dence that overall headache or specific headache type
by itself or in combination with structural brain lesions
results in cognitive impairment.
Strengths and weaknesses of the study
Our study has several strengths, including the large
number of participants drawn independently accord-
ing to headache status from the general population,
classification of headache status through a structured
and standardised telephone interview carried out by
neurologists who were specialised in headache disor-
ders, utilisation of validated automated image
processing
34 to classify volume of white matter hyper-
intensities, and the large amount of available informa-
tion allowing for the control of potential confounding
factors.
Several limitations should also be considered.
Firstly,despitethelargestudysize,thesubgroupscom-
priseda relatively small number ofparticipants, which
should particularly caution the interpretation of the
results for migraine with aura (n=17). Secondly, our
study was cross sectional, which does not necessarily
allow evaluation of the direction of association. How-
ever, most of the participants with headache reported
first onset in young age, when structural brain lesions
are rare. Thirdly, not all participants took part in the
brainimagingsubstudy,whichcouldpotentiallyresult
in selection bias. However, the measured
characteristics,
17 and particularly the distribution of
headache history, did not differ among participants
and non-participants (P=0.38). Fourthly, although
headachestatuswasascertainedbyadetailedinterview
with a headache specialist, information on headaches
may not have been recalled adequately in this older
population. As white matter hyperintensities have
been associated with increased risk of dementia,
14 a
differential bias is possible. Such a bias would,
Table 5 |Mini-mental state examination (MMSE) scores according to headache status and structural brain lesions in
Epidemiology of Vascular Ageing study (n=769) adjusted for age, sex, and education
WMH volume by thirds
No history of severe headache
(n=608) Migraine headache (n=116) Non-migraine headache (n=45)
No (%) Mean (SE) MMSE No (%) Mean (SE) MMSE No (%) Mean (SE) MMSE
Total:
Lowest third (n=259) 214 (35.2) 27.5 (0.1) 35 (30.2) 27.6 (0.4) 10 (22.2) 28.6 (0.5)
Middle third (n=258) 210 (34.5) 27.6 (0.1) 34 (29.3) 27.5 (0.4) 14 (31.1) 27.8 (0.5)
Highest third (n=252) 184 (30.3) 27.5 (0.2) 47 (40.5) 27.9 (0.3) 21 (46.7) 27.8 (0.4)
P value 0.68 0.71 0.42
Deep:
Lowest third (n=259) 212 (34.9) 27.6 (0.1) 34 (29.3) 27.2 (0.4) 13 (28.9) 27.9 (0.5)
Middle third (n=258) 212 (34.9) 27.5 (0.1) 34 (29.3) 27.7 (0.4) 12 (26.7) 28.4 (0.6)
Highest third (n=252) 184 (30.3) 27.5 (0.2) 48 (41.4) 28.1 (0.3) 20 (44.4) 27.8 (0.4)
P value 0.86 0.19 0.63
Periventricular:
Lowest third (n=259) 213 (35.0) 27.4 (0.1) 36 (31.0) 27.7 (0.4) 9 (20.0) 28.7 (0.7)
Middle third (n=257) 208 (34.2) 27.7 (0.1) 33 (28.4) 27.6 (0.4) 16 (35.6) 27.9 (0.4)
Highest third (n=254) 187 (30.8) 27.5 (0.2) 47 (40.5) 27.8 (0.3) 20 (44.4) 27.7 (0.4)
P value 0.44 0.94 0.53
No infarction (n=660) 519 (85.4) 27.6 (0.1) 99 (85.3) 27.7 (0.2) 42 (93.3) 28.0 (0.2)
Any infarct lesion (n=109) 89 (14.6) 27.2 (0.2) 17 (14.7) 27.9 (0.5) 3 (6.7) 27.6 (1.0)
P value 0.17 0.69 0.72
Overall mean (SE) 27.5 (0.1) 27.7 (0.2) 28.1 (0.3)
WMH=white matter hyperintensities; MRI=magnetic resonance imaging. Percentages may not add to 100% owing to rounding.
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betweenheadachestatusandwhitematterhyperinten-
sities. Furthermore, our initial screening question for
headache asked for “severe” headache to identify
patients with considerable headache burden, which
may not allow all people who have headaches to be
captured. However, such a screening tool is often
used in population based headache research.
2237 Fif-
thly,despiteadjustmentforalargenumberofpotential
confounders, residual and unmeasurable confounding
is possible because our study was observational.
Sixthly, our data were collected some time ago.
Althoughtheassociationsbetweenmigraineandstruc-
tural brain lesions or function are unlikely to have
changed, newer imaging techniques are available,
which may lead to more precise detection of lesions.
Lastly, the participants were of higher socioeconomic
status and somewhat healthier than their peer group,
27
which may limit generalisability to other populations.
Comparisons with previous studies
Our findings extend our knowledge of the association
betweenheadacheandwhitematterhyperintensitiesto
non-migraine headache, which is likely to be tension-
type headache, and to older people. Previous popula-
tion based studies could only evaluate the association
between migraine and white matter hyperintensities,
showing increased risk.
203839 In a meta-analysis of
case-control studies, migraine was associated with a
fourfoldincreasedrisk(oddsratio3.9,95%confidence
interval 2.26 to 6.72) of white matter abnormalities.
23
For tension-type headache, our data confirm results
from a previoussmall case-control studyof 63 patients
with chronic primary headache and 54 controls free of
headache.
26 This imaging study found that the preva-
lenceofwhitematterabnormalitieswassimilarforten-
sion-type and migraine headaches (32.1% and 34.3%)
and both were increased compared with controls
(7.4%).
Ourresultsofastrongassociationbetweenmigraine
with aura and deep white matter hyperintensities
extend the findings of the Cerebral Abnormalities in
Migraine, an Epidemiological Risk Analysis (CAM-
ERA) study.
22 In this population based sample of
men and women aged 20 to 60 years from the Nether-
lands, overall migraine was associated with an
increased load of deep white matter hyperintensities
amongwomenbutdidnotdifferaccordingtomigraine
aura status. The association was stronger with higher
frequencyofmigraines,informationthatwasnotavail-
able in our study.
The CAMERA study further showed an association
between migraine with aura and infarct-like lesions
mainly located in the cerebellum and brain stem
(odds ratio 13.7, 95% confidence interval 1.7 to
112).
1022 This finding is supported by a population
based study from Iceland, which found that women
with migraine in mid-life had an increased risk of cer-
ebellar infarct-like lesions in later life.
11 Although our
dataalsosupportanassociationbetweenmigrainewith
aura and brain infarcts, most of these lesions were
located outside the cerebellum or brain stem.
Our data do not indicate an association between
overallor specificheadachetypesandimpairedcogni-
tive function regardless of the presence of structural
brain lesions. While data suggest an association
between white matter hyperintensities and cognitive
impairment,
14 recent findings do not support an asso-
ciation betweencognitiveimpairment and migrainein
older people.
40
Potential biological mechanisms
The mechanisms linking headache in general with
white matter hyperintensities are unclear. White mat-
ter hyperintensities are believed to consist of gliosis
and local loss of myelin resulting from microvascular
damage. In patients with migraine, a haemodynamic
ischaemic process
41 and mitochondrial dysfunction
42
have been hypothesised, but neuropathological inves-
tigations are lacking.
43 Rarely, white matter hyperin-
tensities among patients who have migraine with aura
can be related to a genetically determined small vessel
disease.
44
A potential explanation for the association between
migraine with aura and brain infarcts involves links
between migraine and the endovascular system,
4546
sharedgeneticorvascularriskfactors,
4748orapotential
association with patent foramen ovale.
4950
Implications for clinical practice
Our data confirm the association of migraine with
white matter hyperintensities. They suggest, however,
that this association is not specific to migraine head-
aches but extends to non-migraine headaches, most
likely tension-type headaches. In addition, our data
provide evidence that, irrespective of the underlying
headache type, the existence of brain lesions among
people who have headaches does not result in cogni-
tive impairment. As the association between headache
and brain infarcts is limited to the small subgroup of
patients who have migraine with aura, our data do not
support ordering brain imaging to rule out structural
brain lesions for most people with primary headache
disorders.
Future research
Although it does not seem to currently have any clin-
ical relevance, the relation between migraine with
aura, white matter hyperintensities, and brain infarcts
deserves further investigation. Silent brain infarcts
seem to have the same risk factors and mechanisms
as clinical stroke but they are many times more com-
mon and therefore easier to study. As white matter
hyperintensities have been linked with increased risk
of stroke,
1651 a better understanding of the relation
between migraine with aura and structural brain
lesions could give further insights into whether this
association is limited to specific subgroups and
whether preventive strategies should be tested.
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